Arthur M. Krieg
69Patents
30h-index
34Co-inventors
88Inventor score
Filing activity: Feb 7, 1995 → Dec 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6207646A | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 467 | Expired |
| US6239116A | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 454 | Expired |
| US6406705B1 | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant | Emerging Cross-Sectional Technologies | 386 | Expired |
| US6194388A | Immunomodulatory oligonucleotides | Chemistry; Metallurgy | 329 | Expired |
| US6218371A | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines | Human Necessities | 285 | Expired |
| US6339068B1 | Vectors and methods for immunization or therapeutic protocols | Chemistry; Metallurgy | 281 | Expired |
| US6429199B1 | Immunostimulatory nucleic acid molecules for activating dendritic cells | Chemistry; Metallurgy | 261 | Expired |
| US6214806A | Use of nucleic acids containing unmethylated CPC dinucleotide in the treatment of LPS-associated disorders | Human Necessities | 235 | Expired |
| US6653292B1 | Method of treating cancer using immunostimulatory oligonucleotides | Emerging Cross-Sectional Technologies | 111 | Expired |
| US6949520B1 | Methods related to immunostimulatory nucleic acid-induced interferon | Chemistry; Metallurgy | 110 | Expired |
| US7271156B2 | Immunostimulatory nucleic acids | Human Necessities | 86 | Expired |
| US7956043B2 | 5′ CpG nucleic acids and methods of use | Chemistry; Metallurgy | 69 | Active |
| US7488490B2 | Method of inducing an antigen-specific immune response by administering a synergistic combination of adjuvants comprising unmethylated CpG-containing nucleic acids and a non-nucleic acid adjuvant | Emerging Cross-Sectional Technologies | 67 | Expired |
| US7223741B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 66 | Expired |
| US7615539B2 | Nucleic acid-lipophilic conjugates | Human Necessities | 60 | Expired |
| US6821957B2 | Vectors and methods for immunization or therapeutic protocols | Chemistry; Metallurgy | 57 | Expired |
| US7569553B2 | Nucleic acid compositions for stimulating immune responses | Emerging Cross-Sectional Technologies | 49 | Expired |
| US7402572B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 47 | Expired |
| US7566703B2 | Semi-soft C-class immunostimulatory oligonucleotides | Chemistry; Metallurgy | 44 | Active |
| US7776344B2 | Methods related to immunostimulatory nucleic acid-induced interferon | Chemistry; Metallurgy | 43 | Active |
| US7576066B2 | Nucleic acid compositions for stimulating immune responses | Human Necessities | 43 | Expired |
| US7605138B2 | Nucleic acid compositions for stimulating immune responses | Human Necessities | 42 | Expired |
| US7517861B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 41 | Expired |
| US8058249B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 35 | Expired |
| US7713529B2 | Methods for treating and preventing infectious disease | Emerging Cross-Sectional Technologies | 33 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.